Drugs / dabigatran etexilate

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04157881 Jan 2020 → Jan 2022 atrial fibrillation, venous thromboembolism Population Health Research Institute Completed No outcome recorded

Evidence & citations 18 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as dabigatran etexilate “APO-Dabigatran is one of the first generic formulations of dabigatran etexilate to be introduced into the Canadian market.” NCT04157881
Known as APO-Dabigatran ClinicalTrials.gov intervention name — accepted as the source's own label NCT04157881
Known as BIBR 1048 ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as BIBR 1048 BS RS1 ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as BIBR 1048 MS ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as Dabigatran etexilate accord ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as Dabigatran etexilate leon farma ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as Dabigatran etexilate mesilate ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as DABIGATRAN ETEXILATE MESYLATE ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as Dabigatran etexilate methanesulfonate ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as Dabigatran etexilato ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as Pradaxa ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as Pradaxa (dabigatran etexilate mesylate) ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Known as Prazaxa ChEMBL registry synonym — accepted as the source's own label CHEMBL539697
Action Inhibit “direct thrombin inhibitors (DTIs)” NCT04157881
1

“Thrombin inhibitor” CHEMBL539697

Modality Small molecule “small, water soluble, poorly absorbable, active site-directed molecule” NCT04157881
Route Oral “per oral (PO)” NCT04157881
Target F2 “Thrombin inhibitor” CHEMBL539697